Whether Proton Pump Inhibitors, Administered Prior to or After Surgery, Can Reduce the Incidence and/or Severity of Difficulty Swallowing Foods and/or Liquids,Following Anterior Cervical Surgery
NCT03488147 · Status: WITHDRAWN · Phase: PHASE2 · Type: INTERVENTIONAL
Last updated 2020-11-23
Summary
The researchers wish to investigate whether proton pump inhibitors, administered prior to or after surgery, can reduce the incidence and/or severity of difficulty swallowing foods and/or liquids,following anterior cervical surgery.
Conditions
- Dysphagia
- GERD
- Degenerative Joint Disease
Interventions
- DRUG
-
Esomeprazole
20 mg esomeprazole tablet
- DRUG
-
Placebo Oral Tablet
resembling esomeprazole tablet
Sponsors & Collaborators
-
Icahn School of Medicine at Mount Sinai
lead OTHER
Principal Investigators
-
Andrew C Hecht, MD · Icahn School of Medicine at Mount Sinai
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-31
- Primary Completion
- 2020-07-02
- Completion
- 2020-07-02
- FDA Drug
- Yes
Countries
- United States
Study Locations
More Related Trials
-
Effect of a Combination Oral Formulation of Hyaluronic Acid, Chondroitin Sulphate and Magnesium Trisilicate in Patients With Gastro-Esophageal Reflux Disease Not Fully Satisfied With Their Treatment
NCT04202692 ·Status: COMPLETED ·Phase: NA
-
High Resolution Manometry After Partial Fundoplication for Gastro-oesophageal Reflux
NCT05132816 ·Status: RECRUITING ·Phase: NA
-
[Impedance Measurement for Non-Erosive Reflux Disease
NCT02997527 ·Status: WITHDRAWN ·Phase: NA
-
Impact of Glossopharyngeal Nerve Block on Swallowing Difficulties Caused by Gastroesophageal Reflux Disease
NCT06328205 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients
NCT02619747 ·Status: TERMINATED ·Phase: PHASE3
-
Effect of Proton Pump Inhibitors on CF Pulmonary Exacerbations
NCT01983774 ·Status: COMPLETED ·Phase: PHASE2
-
Effect of Glossopharyngeal Nerve Block on Pharyngeal Dysphagia Induced by Gastroesophageal Reflux Disease
NCT06215794 ·Status: WITHDRAWN ·Phase: NA
-
Study to Evaluate the Safety and Efficacy of CJ-12420 in Patients With Non Erosive Reflux Disease
NCT02556021 ·Status: COMPLETED ·Phase: PHASE3
-
Trial of Electrosurgical Incision Versus Bougie Dilation of Symptomatic Lower Esophageal (Schatzki's) Rings
NCT00204750 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Measurement of Gastric Secretion by MRI Under Inhibition by ProtonPump Inhibitors in Healthy Subjects & in GERD Patients
NCT01212614 ·Status: COMPLETED ·Phase: NA
-
Compound Sodium Alginate Double Action Chewable Tablets 4-hour Esophageal pH Study in GERD Patients
NCT01872897 ·Status: COMPLETED ·Phase: PHASE3
-
Chronic Posterior Laryngitis With Suspected Laryngopharyngeal Reflux
NCT00628667 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Sucralfate Slurry in Patients With Eosinophilic Esophagitis
NCT02353078 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Systematic IPP VS Symptomatic IPP in GERD Prevention After POEM for Achalasia. . A Comparative Retrospective Analysis
NCT04740437 ·Status: UNKNOWN
-
Evolution of the Chicago Classification: Bridging Physiology and Mechanics
NCT06883175 ·Status: RECRUITING ·Phase: NA
-
Mechanisms Preventing Pharyngeal Reflux
NCT05696184 ·Status: RECRUITING ·Phase: NA
-
Rabeprazole in Subjects With Gastroesophageal Reflux Disease (GERD)
NCT00222170 ·Status: COMPLETED ·Phase: PHASE2
-
Clinical Trial to Evaluate the Safety and Efficacy of JP-1366 in Patients With Erosive Gastroesophageal Reflux Disease
NCT04282954 ·Status: COMPLETED ·Phase: PHASE2
-
A Novel Endoloop Pre-test to Treat Gastroesophageal Reflux
NCT05192538 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Efficacy and Safety of Controlled Release Arbaclofen Placarbil (XP19986) in Patients With Gastroesophageal Reflux Disease
NCT00838396 ·Status: COMPLETED ·Phase: PHASE2
-
Treatment Of Gastroesophageal Reflux Disease By Endoscopic Fundoplication, A Placebo-Controlled Study
NCT00235677 ·Status: COMPLETED ·Phase: PHASE3
-
Diagnostic Yield of Post PRandial Esophageal High Resolution Impedance Manometry in Patients With Gastro-Esophageal Reflux Disease Symptoms Resistant to Proton Pump Inhibitor Therapy
NCT03596476 ·Status: RECRUITING ·Phase: NA
-
Laryngopharyngeal Reflux and Proton Pump Inhibitor (PPI) Treatment
NCT00204698 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Effect of Acid Suppression With Esomeprazole on Vocal Cord Granulomas
NCT00567658 ·Status: WITHDRAWN ·Phase: PHASE3
-
Oral Fosamprenavir + Sodium Alginate for GERD
NCT06704100 ·Status: NOT_YET_RECRUITING ·Phase: PHASE2